JP2020073536A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020073536A5 JP2020073536A5 JP2019235539A JP2019235539A JP2020073536A5 JP 2020073536 A5 JP2020073536 A5 JP 2020073536A5 JP 2019235539 A JP2019235539 A JP 2019235539A JP 2019235539 A JP2019235539 A JP 2019235539A JP 2020073536 A5 JP2020073536 A5 JP 2020073536A5
- Authority
- JP
- Japan
- Prior art keywords
- nucleic acid
- protein
- seq
- pharmaceutical composition
- human
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 102000039446 nucleic acids Human genes 0.000 claims 18
- 108020004707 nucleic acids Proteins 0.000 claims 18
- 150000007523 nucleic acids Chemical class 0.000 claims 18
- 108090000623 proteins and genes Proteins 0.000 claims 13
- 101001104102 Homo sapiens X-linked retinitis pigmentosa GTPase regulator Proteins 0.000 claims 12
- 239000008194 pharmaceutical composition Substances 0.000 claims 12
- 102000004169 proteins and genes Human genes 0.000 claims 10
- 102000050188 human RPGR Human genes 0.000 claims 8
- 239000013603 viral vector Substances 0.000 claims 8
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims 6
- 241000702421 Dependoparvovirus Species 0.000 claims 6
- 208000007014 Retinitis pigmentosa Diseases 0.000 claims 6
- 239000013598 vector Substances 0.000 claims 6
- 102100040092 X-linked retinitis pigmentosa GTPase regulator Human genes 0.000 claims 4
- 102000013446 GTP Phosphohydrolases Human genes 0.000 claims 3
- 108091006109 GTPases Proteins 0.000 claims 3
- 230000004777 loss-of-function mutation Effects 0.000 claims 3
- 241000702423 Adeno-associated virus - 2 Species 0.000 claims 2
- 102000004437 G-Protein-Coupled Receptor Kinase 1 Human genes 0.000 claims 2
- 101000611338 Homo sapiens Rhodopsin Proteins 0.000 claims 2
- 206010025421 Macule Diseases 0.000 claims 1
- 239000012530 fluid Substances 0.000 claims 1
- 238000000520 microinjection Methods 0.000 claims 1
- 210000001328 optic nerve Anatomy 0.000 claims 1
- 208000024891 symptom Diseases 0.000 claims 1
- 230000002123 temporal effect Effects 0.000 claims 1
- 230000003612 virological effect Effects 0.000 claims 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021172128A JP7198329B2 (ja) | 2014-07-24 | 2021-10-21 | 網膜色素変性症のためのｒｐｇｒ遺伝子治療 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462028638P | 2014-07-24 | 2014-07-24 | |
| US62/028,638 | 2014-07-24 | ||
| JP2017525514A JP6654760B2 (ja) | 2014-07-24 | 2015-07-17 | 網膜色素変性症のためのｒｐｇｒ遺伝子治療 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017525514A Division JP6654760B2 (ja) | 2014-07-24 | 2015-07-17 | 網膜色素変性症のためのｒｐｇｒ遺伝子治療 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021172128A Division JP7198329B2 (ja) | 2014-07-24 | 2021-10-21 | 網膜色素変性症のためのｒｐｇｒ遺伝子治療 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020073536A JP2020073536A (ja) | 2020-05-14 |
| JP2020073536A5 true JP2020073536A5 (enExample) | 2020-12-03 |
| JP6966532B2 JP6966532B2 (ja) | 2021-11-17 |
Family
ID=55163577
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017525514A Active JP6654760B2 (ja) | 2014-07-24 | 2015-07-17 | 網膜色素変性症のためのｒｐｇｒ遺伝子治療 |
| JP2019235539A Active JP6966532B2 (ja) | 2014-07-24 | 2019-12-26 | 網膜色素変性症のためのｒｐｇｒ遺伝子治療 |
| JP2021172128A Active JP7198329B2 (ja) | 2014-07-24 | 2021-10-21 | 網膜色素変性症のためのｒｐｇｒ遺伝子治療 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017525514A Active JP6654760B2 (ja) | 2014-07-24 | 2015-07-17 | 網膜色素変性症のためのｒｐｇｒ遺伝子治療 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021172128A Active JP7198329B2 (ja) | 2014-07-24 | 2021-10-21 | 網膜色素変性症のためのｒｐｇｒ遺伝子治療 |
Country Status (18)
| Country | Link |
|---|---|
| US (2) | US10314924B2 (enExample) |
| EP (2) | EP3191139B1 (enExample) |
| JP (3) | JP6654760B2 (enExample) |
| CN (1) | CN107206105A (enExample) |
| CA (1) | CA2991750C (enExample) |
| CY (1) | CY1123793T1 (enExample) |
| DK (2) | DK3821912T3 (enExample) |
| ES (2) | ES2987090T3 (enExample) |
| FI (1) | FI3821912T3 (enExample) |
| HR (2) | HRP20202023T1 (enExample) |
| HU (2) | HUE068183T2 (enExample) |
| LT (2) | LT3821912T (enExample) |
| PL (2) | PL3821912T3 (enExample) |
| PT (2) | PT3821912T (enExample) |
| RS (2) | RS65909B1 (enExample) |
| SI (2) | SI3191139T1 (enExample) |
| SM (2) | SMT202400309T1 (enExample) |
| WO (1) | WO2016014353A1 (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SMT202400309T1 (it) * | 2014-07-24 | 2024-11-15 | Massachusetts Eye & Ear Infirmary | Terapia genica rpgr per la retinite pigmentosa |
| WO2016098078A2 (en) * | 2014-12-19 | 2016-06-23 | Novartis Ag | Dimerization switches and uses thereof |
| AU2016228751B2 (en) | 2015-03-11 | 2022-01-13 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Rp2 vectors for treating x-linked retinitis pigmentosa |
| GB201516066D0 (en) | 2015-09-10 | 2015-10-28 | Young & Co Llp D | Treatment of retinitis pigmentosa |
| GB201704192D0 (en) | 2017-03-16 | 2017-05-03 | Nightstarx Ltd | Treatment of Retinitis Pigmentosa |
| WO2019077159A1 (en) * | 2017-10-20 | 2019-04-25 | INSERM (Institut National de la Santé et de la Recherche Médicale) | METHODS OF EXPRESSING POLYNUCLEOTIDE OF INTEREST IN CONE PHOTORECCEPTORS OF A SUBJECT COMPRISING SUB-RETINAL ADMINISTRATION OF A THERAPEUTICALLY EFFECTIVE AMOUNT OF A RECOMBINANT AAV9 DERIVATIVE VECTOR |
| MY204271A (en) * | 2017-11-15 | 2024-08-20 | Ucl Business Ltd | Viral vectors comprising rdh12 coding regions and methods of treating retinal dystrophies |
| IL296262A (en) * | 2020-03-11 | 2022-11-01 | Massachusetts Eye & Ear Infirmary | Gene therapy for nmnat1-related retinal degeneration |
| CN120350069A (zh) * | 2024-01-12 | 2025-07-22 | 北京中因科技有限公司 | 视网膜色素变性动物模型及其构建方法和应用 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4980286A (en) | 1985-07-05 | 1990-12-25 | Whitehead Institute For Biomedical Research | In vivo introduction and expression of foreign genetic material in epithelial cells |
| IL79289A (en) | 1985-07-05 | 1992-01-15 | Whitehead Biomedical Inst | Introduction and expression of foreign genetic material into keratinocytes using a recombinant retrovirus |
| EP0633318A1 (en) | 1987-09-11 | 1995-01-11 | Whitehead Institute For Biomedical Research | Transduced fibroblasts and uses therefor |
| HK1008400A1 (en) | 1987-12-11 | 1999-05-07 | Whitehead Institute For Biomedical Research | Genetic modification of endothelial cells |
| ATE152169T1 (de) | 1988-02-05 | 1997-05-15 | Whitehead Biomedical Inst | Modifizierte hepatozyten und deren anwendung |
| ATE147102T1 (de) | 1990-10-31 | 1997-01-15 | Somatix Therapy Corp | Nützliche retrovirale vektoren für die gentherapie |
| US5767079A (en) * | 1992-07-08 | 1998-06-16 | Celtrix Pharmaceuticals, Inc. | Method of treating ophthalmic disorders using TGF -β |
| AU2044901A (en) | 1999-11-24 | 2001-06-04 | Cornell Research Foundation Inc. | Inherited retinal diseases at the canine rp3 locus: linkage, marker- and mutation-based tests |
| GB0008801D0 (en) | 2000-04-10 | 2000-05-31 | Medical Res Council | Sequences |
| CN102925445A (zh) * | 2011-08-08 | 2013-02-13 | 刘军 | 一种获得rpgr 基因新的转录剪切形式的方法 |
| AU2013287281B2 (en) * | 2012-07-11 | 2018-04-26 | The Trustees Of The University Of Pennsylvania | AAV-mediated gene therapy for RPGR x-linked retinal degeneration |
| GB201412011D0 (en) * | 2014-07-04 | 2014-08-20 | Ucl Business Plc | Treatments |
| SMT202400309T1 (it) * | 2014-07-24 | 2024-11-15 | Massachusetts Eye & Ear Infirmary | Terapia genica rpgr per la retinite pigmentosa |
-
2015
- 2015-07-17 SM SM20240309T patent/SMT202400309T1/it unknown
- 2015-07-17 RS RS20240901A patent/RS65909B1/sr unknown
- 2015-07-17 ES ES20199208T patent/ES2987090T3/es active Active
- 2015-07-17 SM SM20200715T patent/SMT202000715T1/it unknown
- 2015-07-17 LT LTEP20199208.8T patent/LT3821912T/lt unknown
- 2015-07-17 HR HRP20202023TT patent/HRP20202023T1/hr unknown
- 2015-07-17 LT LTEP15825383.1T patent/LT3191139T/lt unknown
- 2015-07-17 ES ES15825383T patent/ES2834402T3/es active Active
- 2015-07-17 PL PL20199208.8T patent/PL3821912T3/pl unknown
- 2015-07-17 HR HRP20241154TT patent/HRP20241154T1/hr unknown
- 2015-07-17 US US15/328,617 patent/US10314924B2/en active Active
- 2015-07-17 JP JP2017525514A patent/JP6654760B2/ja active Active
- 2015-07-17 PL PL15825383T patent/PL3191139T3/pl unknown
- 2015-07-17 SI SI201531413T patent/SI3191139T1/sl unknown
- 2015-07-17 EP EP15825383.1A patent/EP3191139B1/en active Active
- 2015-07-17 FI FIEP20199208.8T patent/FI3821912T3/fi active
- 2015-07-17 EP EP20199208.8A patent/EP3821912B1/en active Active
- 2015-07-17 CN CN201580051512.3A patent/CN107206105A/zh active Pending
- 2015-07-17 SI SI201532022T patent/SI3821912T1/sl unknown
- 2015-07-17 DK DK20199208.8T patent/DK3821912T3/da active
- 2015-07-17 WO PCT/US2015/040866 patent/WO2016014353A1/en not_active Ceased
- 2015-07-17 HU HUE20199208A patent/HUE068183T2/hu unknown
- 2015-07-17 PT PT201992088T patent/PT3821912T/pt unknown
- 2015-07-17 RS RS20201416A patent/RS61307B1/sr unknown
- 2015-07-17 DK DK15825383.1T patent/DK3191139T3/da active
- 2015-07-17 HU HUE15825383A patent/HUE052781T2/hu unknown
- 2015-07-17 PT PT158253831T patent/PT3191139T/pt unknown
- 2015-07-17 CA CA2991750A patent/CA2991750C/en active Active
-
2019
- 2019-06-10 US US16/436,521 patent/US11045558B2/en active Active
- 2019-12-26 JP JP2019235539A patent/JP6966532B2/ja active Active
-
2021
- 2021-01-05 CY CY20211100002T patent/CY1123793T1/el unknown
- 2021-10-21 JP JP2021172128A patent/JP7198329B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2020073536A5 (enExample) | ||
| JP2017523239A5 (enExample) | ||
| JP2015508760A5 (enExample) | ||
| RU2018112506A (ru) | Лечение пигментного ретинита | |
| HRP20202023T1 (hr) | Genska terapija rpgr za liječenje retinitis pigmentose | |
| JP2018537984A5 (enExample) | ||
| Manfredi et al. | Combined rod and cone transduction by adeno-associated virus 2/8 | |
| JP2021507687A5 (enExample) | ||
| JP2019524090A5 (enExample) | ||
| JP2021502978A5 (enExample) | ||
| RU2019103488A (ru) | Способы и композиции для лечения нарушений и заболеваний, связанных с rdh12 | |
| BR112021012048A2 (pt) | Fator complementar i e cofator de fator complementar i, vetores que codificam os mesmos e uso terapêutico | |
| JP2018526994A5 (enExample) | ||
| RU2019126509A (ru) | Выделенный модифицированный белок VP1 капсида аденоассоциированного вируса 5 серотипа (AAV5), капсид и вектор на его основе | |
| IL308645A (en) | Viral vectors comprising rdh12 coding regions and methods of treating retinal dystrophies | |
| JP2018509154A5 (enExample) | ||
| US20230220420A1 (en) | Gene therapy for bardet-biedl syndrome | |
| US20170137480A1 (en) | Rpgr-ofr15 variant gene in the treatment of retinitis pigmentosa | |
| CN113383011A (zh) | 密码子优化的补体因子i | |
| JPWO2021084133A5 (enExample) | ||
| JPWO2022026632A5 (enExample) | ||
| Hauswirth | Retinal gene therapy using adeno-associated viral vectors: multiple applications for a small virus | |
| JP2020535203A5 (enExample) | ||
| WO2018090042A1 (en) | Methods of treating heart failure | |
| Dhooge et al. | Gene therapy for inherited retinal diseases |